JNJ (Johnson & Johnson) Total Equity: $81,186 Mil (As of Mar. 2026)


JNJ Johnson & Johnson JNJ
85 GF Score
Price $258.51
GF Value $190.57
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Total Equity?

Johnson & Johnson JNJ +1.51% 85 Total Equity is $81,186 Mil as of Mar. 2026. GuruFocus rates JNJ with a GF Score™ of 85/100 and a GF Value™ of $190.57 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Johnson & Johnson's total equity for the quarter that ended in Mar. 2026 was $81,186 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Johnson & Johnson Total Equity Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Total Equity Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74,023.00 76,804.00 68,774.00 71,490.00 81,544.00

Johnson & Johnson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78,109.00 78,473.00 79,277.00 81,544.00 81,186.00
JNJ
85GF Score
Johnson & Johnson JNJ
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Johnson & Johnson's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=199210-117666
=81,544

Johnson & Johnson's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=200894-119708
=81,186

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $81,186 Mil mean?
Johnson & Johnson (JNJ) has a Total Equity of $81,186 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Johnson & Johnson and its competitors.
Is Johnson & Johnson's Total Equity too high?
Johnson & Johnson's current Total Equity is $81,186 Mil. Overall, Johnson & Johnson has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Total Equity compare to ABBV and MRK?
Johnson & Johnson's Total Equity of $81,186 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Johnson & Johnson and its competitors. Johnson & Johnson's current Total Equity is $81,186 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is $190.57, compared to a current price of $258.51 — trading 35.7% above its estimated fair value. The current Total Equity is $81,186 Mil. Johnson & Johnson's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Johnson & Johnson (JNJ), the current Total Equity is $81,186 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $258.51 is trading 35.7% above its estimated GF Value™ of $190.57. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for JNJ:

  • Total Equity: $81,186 Mil
  • GF Value™: $190.57 vs. price of $258.51 (35.7% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
85GF Score

Get the complete analysis for JNJ

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$258.51
Price
$190.57
GF Value